Ispire Technology Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Ispire Technology Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $127.49M | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | $151.91M | Sep 15, 2025 |
| FY2024 | Jun 30, 2023 | $115.61M | Sep 27, 2024 |
| FY2023 | Jun 30, 2022 | $88.10M | Sep 19, 2023 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $22.65M | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | $29.78M | Sep 15, 2025 |
| FY2024 | Mar 31, 2024 | $19.22M | Sep 27, 2024 |
| FY2024 | Dec 31, 2023 | $6.25M | Sep 27, 2024 |
| FY2024 | Sep 30, 2023 | $6.84M | Sep 27, 2024 |
| FY2024 | Jun 30, 2023 | $20.78M | Sep 27, 2024 |
| FY2023 | Jun 30, 2022 | $13.31M | Sep 19, 2023 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($39.24M) | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | ($14.77M) | Sep 15, 2025 |
| FY2024 | Mar 31, 2024 | ($5.93M) | Sep 27, 2024 |
| FY2024 | Dec 31, 2023 | ($3.99M) | Sep 27, 2024 |
| FY2024 | Sep 30, 2023 | ($1.34M) | Sep 27, 2024 |
| FY2024 | Jun 30, 2023 | ($6.00M) | Sep 27, 2024 |
| FY2023 | Jun 30, 2022 | ($1.87M) | Sep 19, 2023 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($37.85M) | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | ($13.89M) | Sep 15, 2025 |
| FY2024 | Mar 31, 2024 | ($5.66M) | Sep 27, 2024 |
| FY2024 | Dec 31, 2023 | ($3.92M) | Sep 27, 2024 |
| FY2024 | Sep 30, 2023 | ($878.2K) | Sep 27, 2024 |
| FY2024 | Jun 30, 2023 | ($4.47M) | Sep 27, 2024 |
| FY2023 | Jun 30, 2022 | ($988.7K) | Sep 19, 2023 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $363.3K | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | $779.2K | Sep 15, 2025 |
| FY2024 | Jun 30, 2023 | $146.1K | Sep 27, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($7.37M) | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | ($18.30M) | Sep 15, 2025 |
| FY2024 | Mar 31, 2024 | ($16.88M) | Sep 27, 2024 |
| FY2024 | Dec 31, 2023 | ($20.23M) | Sep 27, 2024 |
| FY2024 | Sep 30, 2023 | ($13.12M) | Sep 27, 2024 |
| FY2024 | Jun 30, 2023 | ($8.46M) | Sep 27, 2024 |
| FY2023 | Jun 30, 2022 | ($7.56M) | Sep 19, 2023 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.10M | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | $1.97M | Sep 15, 2025 |
| FY2024 | Jun 30, 2023 | $1.02M | Sep 27, 2024 |
| FY2023 | Jun 30, 2022 | $121.5K | Sep 19, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $102.22M | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | $122.64M | Sep 15, 2025 |
| FY2024 | Mar 31, 2024 | $107.98M | Sep 27, 2024 |
| FY2024 | Dec 31, 2023 | $90.39M | Sep 27, 2024 |
| FY2024 | Sep 30, 2023 | $88.14M | Sep 27, 2024 |
| FY2024 | Jun 30, 2023 | $90.40M | Sep 27, 2024 |
| FY2023 | Jun 30, 2022 | $100.74M | Sep 19, 2023 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $101.61M | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | $88.18M | Sep 15, 2025 |
| FY2024 | Mar 31, 2024 | $72.12M | Sep 27, 2024 |
| FY2024 | Dec 31, 2023 | $61.25M | Sep 27, 2024 |
| FY2024 | Sep 30, 2023 | $56.99M | Sep 27, 2024 |
| FY2024 | Jun 30, 2023 | $58.93M | Sep 27, 2024 |
| FY2023 | Jun 30, 2022 | $88.97M | Sep 19, 2023 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $604.7K | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | $34.46M | Sep 15, 2025 |
| FY2024 | Mar 31, 2024 | $35.86M | Sep 27, 2024 |
| FY2024 | Dec 31, 2023 | $29.15M | Sep 27, 2024 |
| FY2024 | Sep 30, 2023 | $31.14M | Sep 27, 2024 |
| FY2025 | Jun 30, 2023 | $31.47M | Sep 15, 2025 |
| FY2024 | Jun 30, 2022 | $11.77M | Sep 27, 2024 |
| FY2023 | Jun 30, 2021 | $13.76M | Sep 19, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($48.07M) | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | ($8.83M) | Sep 15, 2025 |
| FY2024 | Mar 31, 2024 | ($5.32M) | Sep 27, 2024 |
| FY2024 | Dec 31, 2023 | $609.3K | Sep 27, 2024 |
| FY2024 | Sep 30, 2023 | $4.60M | Sep 27, 2024 |
| FY2024 | Jun 30, 2023 | $5.94M | Sep 27, 2024 |
| FY2023 | Jun 30, 2022 | $11.95M | Sep 19, 2023 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $24.35M | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | $35.07M | Sep 15, 2025 |
| FY2024 | Jun 30, 2023 | $40.30M | Sep 27, 2024 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Sep 15, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Sep 27, 2024 |
| FY2024 | Jun 30, 2023 | 0 | Sep 27, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Sep 19, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Sep 15, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Sep 27, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Sep 19, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 57.19M | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | 56.47M | Sep 15, 2025 |
| FY2024 | Jun 30, 2023 | 54.22M | Sep 27, 2024 |
| FY2023 | Jun 30, 2022 | 50.00M | Sep 19, 2023 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Jun 30, 2023 | $3.36M | Sep 19, 2023 |
| FY2023 | Jun 30, 2022 | $469.6K | Sep 19, 2023 |